News
Hosted on MSN16d
Pfizer Expands Cost-Cutting Measures, Reaffirms OutlookThe sum was factored into the company’s sales and earnings outlook for the year, he said. Meanwhile, Pfizer expanded its ...
16d
Investor's Business Daily on MSNS&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters ProfitPfizer stock inched down Tuesday on a mixed first-quarter report. Sales missed, but cost cutting led to strong earnings.
Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed ...
Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...
Pfizer’s pipeline is robust, with RSV vaccine expansions and AI-driven R&D enhancing long-term prospects. Cost-cutting measures, including manufacturing optimization, improved adjusted gross ...
Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and reported lower first-quarter revenue due to declining sales of its ...
Photo: ABC News Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic.
(Reuters) -Pfizer said on Tuesday it would generate ... about $7.7 billion in savings by the end of 2027 from its cost-cutting programs. That includes an additional $500 million in R&D savings ...
Pfizer on Tuesday reaffirmed its outlook for ... The company launched its multiyear cost-cutting plan in 2023 after the drugmaker miscalculated demand for its Covid-19 products.
(Reuters) -Pfizer said on ... LEANING ON COST SAVINGS The company said it now expects about $7.7 billion in savings by the end of 2027 from its cost-cutting programs. That includes an additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results